home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Endpoint Protection in Rare Disease Trials: Safeguarding Data Integrity for Reliable Outcomes

 
  January 24, 2024  
     
 
Xtalks, Online
2024-02-22


This webinar will explore strategies to build a comprehensive approach to endpoint protection in rare disease clinical trials, thereby ensuring the integrity and reliability of study outcomes. The integrity of clinical trials depends on accurate and reliable data, making the protection of endpoints a critical aspect of the entire process. Endpoints, which are specific outcomes used to measure the effectiveness of an intervention, must be safeguarded to ensure the validity and credibility of the trial results. Endpoint protection is particularly important in rare disease trials as these studies often involve small patient populations and face distinct methodological challenges. Every data point is essential to the success of the study.

Join this webinar to gain insights into essential strategies for constructing a robust framework for endpoint protection in rare disease clinical trials.

Keywords: Clinical Trials, Clinical Research, CRO, Clinical Trial Data, Clinical Data, Rare Disease Clinical Trials, Clinical Trial Endpoints, Rare Diseases/Orphan Drugs
 
 
Organized by: Xtalks
Invited Speakers: Angi Robinson, Senior Vice President, Specialty Areas, Premier Research
 
Deadline for Abstracts: 2024-02-22
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.